Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients

Clinical trial NCT01040780 · COMPLETED

Trial details

NCT number: NCT01040780
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2009-02-01
Primary completion: 2010-03-01
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.